David Malcom Rodman

Companies

• Mineralys Therapeutics, Inc.Chief Medical Officer Feb 9, 2023 to now¹
• Alpine Immune SciencesOfficer Apr 22, 2016 to Jan 5, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMineralys Therapeutics, Inc. MLYS51,384 shares³$1.1M at $21.64Aug 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 10, 2026Sold 2,170 shares at $27.09 of Mineralys Therapeutics, Inc.³
• Aug 10, 2026Exercised options 2,170 shares at $16.00 of Mineralys Therapeutics, Inc.³
• Jul 17, 2026Sold 416 shares at $26.53 of Mineralys Therapeutics, Inc.⁴
• Jul 17, 2026Exercised options 416 shares at $15.44 of Mineralys Therapeutics, Inc.⁴
• Jul 15, 2026Sold 6,349 shares at $26.61 of Mineralys Therapeutics, Inc.⁵
• Jul 13, 2026Sold 14,058 shares at $27.58 of Mineralys Therapeutics, Inc.⁵
• Jul 13, 2026Exercised options 6,349 shares at $1.08 of Mineralys Therapeutics, Inc.⁵
• Jul 13, 2026Exercised options 4,167 shares at $14.25 of Mineralys Therapeutics, Inc.⁵
• Jul 13, 2026Exercised options 3,542 shares at $10.20 of Mineralys Therapeutics, Inc.⁵
• Jul 9, 2026Sold 2,171 shares at $30.30 of Mineralys Therapeutics, Inc.⁶
• Jul 9, 2026Exercised options 2,171 shares at $16.00 of Mineralys Therapeutics, Inc.⁶
• Jun 17, 2026Sold 4,584 shares at $25.00 of Mineralys Therapeutics, Inc.⁷
• Jun 17, 2026Exercised options 417 shares at $15.44 of Mineralys Therapeutics, Inc.⁷
• Jun 17, 2026Exercised options 4,167 shares at $14.25 of Mineralys Therapeutics, Inc.⁷
• Jun 15, 2026Sold 9,890 shares at $23.81 of Mineralys Therapeutics, Inc.⁷
• Jun 15, 2026Exercised options 3,542 shares at $10.20 of Mineralys Therapeutics, Inc.⁷
• Jun 12, 2026Sold 6,349 shares at $23.93 of Mineralys Therapeutics, Inc.⁸
• Jun 12, 2026Exercised options 6,349 shares at $1.08 of Mineralys Therapeutics, Inc.⁸
• Jun 10, 2026Sold 2,170 shares at $25.00 of Mineralys Therapeutics, Inc.⁸
• Jun 10, 2026Exercised options 2,170 shares at $16.00 of Mineralys Therapeutics, Inc.⁸
• May 18, 2026Sold 417 shares at $27.55 of Mineralys Therapeutics, Inc.⁹
• May 18, 2026Exercised options 417 shares at $15.44 of Mineralys Therapeutics, Inc.⁹
• May 13, 2026Sold 14,056 shares at $28.58 of Mineralys Therapeutics, Inc.¹⁰
• May 13, 2026Exercised options 4,166 shares at $14.25 of Mineralys Therapeutics, Inc.¹⁰
• May 13, 2026Exercised options 3,541 shares at $10.20 of Mineralys Therapeutics, Inc.¹⁰